Coding accuracy of administrative drug claims in the Ontario Drug Benefit database

Canadian Journal of Clinical Pharmacology

Volumn 10, Issue 2, 2003, Pages 67-71

  Levy, Adrian R ^a,b   O'Brien, Bernie J ^c,d   Sellors, Connie ^c   Grootendorst, Paul ^c,d   Willison, Donald ^c,d  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CENTRE FOR EVALUATION OF MEDICINES   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Coding; Pharmacoepidemiology; Prescription drugs; Reliability

Indexed keywords

ARTICLE; DATA BASE; DRUG IDENTIFICATION; LOGISTIC REGRESSION ANALYSIS; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; RELIABILITY;

EID: 0038397012     PISSN: 1198581X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. House of Commons Standing Committee on Industry. Drug costs in Canada. Ottawa: Government of Canada, 1997.
2. The Striking a Balance and Evidence Based Decision Making Working Groups. Directions for a pharmaceutical policy in Canada. National Forum on Health, 1997. 〈http://wwwnfh.hc-sc.gc.ca/publicat/finvol2/pharm/back.htm〉 (Version current at January 15, 2003).
3. The Drug Expenditure Longitudinal Trend Analysis (DELTA) Report Summary of Findings. Mississauga: Glaxo Wellcome Inc and Brogan Inc, 2000.
4. Tamblyn RM, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995;48:999-1009.
5. Bates DW. Frequency, consequences and prevention of adverse drug events. J Qual Clin Pract 1999;19:13-7.
6. Manasse HR Jr. Toward defining and applying a higher standard of quality for medication use in the United States. Am J Health Syst Pharm 1995;52:374-9.
7. Jackevicius CA, Anderson GM, Leiter L, Tu JV. Use of the statins in patients after acute myocardial infarction: Does evidence change practice? Arch Intern Med 2001;161:183-8.
8. Tu JV, Austin P, Rochon P, Zhang H. Secondary prevention after acute myocardial infarction, congestive heart failure and coronary artery bypass graft surgery in Ontario. Toronto: Institute for Clinical and Evaluative Sciences, 1999:199-238.
9. Levy AR, Tamblyn RM, McLeod PJ, Fitchett D, Abrahamowicz M. The effect of physicians' training on prescribing beta-blockers for secondary prevention of myocardial infarction in the elderly. Ann Epidemiol 2002;12:86-9.